 FSD Pharma Inc NASDAQ:HUGE CSE:HUGE FRA:0K9A has entered into a license agreement with Innovet Italia SRL to develop US Food and Drug Administration-approved veterinary drugs for the treatment of gastrointestinal diseases in dogs and cats. Under the agreement, Innovet granted the company a license to use ultramicronized-palmitoylethanolamide ultramicronized PEA or ultra-micro PEA to develop the drugs. 